Kennislacune

This literature review shows there is a knowledge gap on immunosuppression and immunomodulation in IIM, except for IVIg in refractory DM.

The defined search question remains unanswered:

What are the effects (benefits and harms) of immunosuppressant and immunomodulatory treatments for IIM?

There is a great need for large RCTs on immunosuppression and immunomodulation in IIM.